Tocilizumab Recall Demands Rapid Inventory Controls
FDA recalls one lot of IV tocilizumab-aazg over potential glass contamination, prompting immediate quarantine, inventory tracing, exposure review, and patient safety monitoring.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.